Translate
Santhera Pharmaceuticals Holding Ag
About
15.64CHF-0.44 -2.74%
Closed • Updated at 19:46 GMT+00:00Market Cap$288.29M
Volume74.8K
Beta1.44
RSI39.92
Gross Margin18.74%
Santhera Pharmaceuticals Holding Ag — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 30 2026
Santhera Proposes Dr. Srishti Gupta as New Member of the Board of Directors
Apr 28 2026
Santhera Announces Positive AIFA Board Decision on Reimbursement of AGAMREE® (vamorolone) in Italy
Apr 28 2026
Santhera Pharmaceuticals Full Year Results for the Year Ended 31 December 2025
Apr 27 2026
Santhera Receives Positive CHMP Opinion to Expand AGAMREE® (vamorolone) Use in Pediatric DMD Patients Aged Two and Older in the EU
Apr 23 2026
Santhera Appoints Orlando Oliveira as Chief Executive Officer